ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

8 links0 made here, not in the record15 judgments2 judges (the rules as one: Rule based)1 record change seen
Claude Opus 5.5Rule basedRecord updated on ClinicalTrials.gov
Oct 12Oct 19Oct 26Nov 2Nov 9Nov 16TodayNCT03179904TVB-2640 and TrastuzumabWith Paclitaxel orEndocrine Therapy forTreatment of HER2 PositiveMetastatic Breast CancerMayo ClinicPhase 2 · completedRECORDThe record itselfVersions seen nightly since Sep 25, 2…›Oct 9 · ClinicalTrials.gov record · Version of 2026-10-09Version of 2026-10-09CONDITIONSBreast NeoplasmsNo longer in the registry's filing›As of now · Rule based · Main conditionMain conditionDRUGSAnastrozoleIntervention entry›Nov 2 · Claude Opus 5.5 · Background · optionNov 18 · Rule based · BackgroundBackground · optionTVB-2640Entry “Denifanstat”, read by our name…›Nov 2 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · BackgroundBackgroundExemestaneIntervention entry›Nov 2 · Claude Opus 5.5 · Background · optionNov 18 · Rule based · BackgroundBackground · optionFulvestrantIntervention entry›Nov 2 · Claude Opus 5.5 · Background · partnerNov 18 · Rule based · BackgroundBackground · partnerLetrozoleIntervention entry›Nov 2 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · BackgroundBackgroundPaclitaxelIntervention entry›Nov 2 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · BackgroundBackgroundTrastuzumabIntervention entry›Nov 2 · Claude Opus 5.5 · Background · partnerNov 18 · Rule based · BackgroundBackground · partner

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

Anastrozole

From the registry record2 judgments on this link
Role in the study, from the registry to what was judged
RegistryEntry “Anastrozole”the record gives no role
→judged=agrees
How the 2 judgments split100%of judgments with a known value say Background · option
Background · option · 2

All judgments on this study

WhenLinkJudgeDecisionState
Oct 9The record itselfClinicalTrials.gov recordVersion of 2026-10-09Record change
Nov 2AnastrozoleClaude Opus 5.5Background · optionCurrent
Nov 2TVB-2640Claude Opus 5.5BackgroundCurrent
Nov 2ExemestaneClaude Opus 5.5Background · optionCurrent
Nov 2FulvestrantClaude Opus 5.5Background · partnerCurrent
Nov 2LetrozoleClaude Opus 5.5BackgroundCurrent
Nov 2PaclitaxelClaude Opus 5.5BackgroundCurrent
Nov 2TrastuzumabClaude Opus 5.5Background · partnerCurrent
Nov 18AnastrozoleRule based · role ruleBackgroundAgrees
Nov 18TVB-2640Rule based · role ruleBackgroundAgrees
Nov 18ExemestaneRule based · role ruleBackgroundAgrees
Nov 18FulvestrantRule based · role ruleBackgroundAgrees
Nov 18LetrozoleRule based · role ruleBackgroundAgrees
Nov 18PaclitaxelRule based · role ruleBackgroundAgrees
Nov 18TrastuzumabRule based · role ruleBackgroundAgrees
As of nowBreast NeoplasmsRule based · main-condition ruleMain conditionCurrent

The rules, in plain words

“Rule based” means one of these decided, not a model or a person. Each runs every night over every study.

Which drugs a study tests

Reads each treatment the study lists and the arms it is in. A drug only in the experimental arm is tested. A drug in every arm while something else changes between the arms is given beside it. A drug only in the control arm is the comparator. Placebo, procedures and usual care are known by name.

Where the whole record has been read, that reading's answer replaces the rule's.

What a study is mainly about

Starts from the first condition ClinicalTrials.gov files the study under. It moves to a narrower one only when the study's own title or listed conditions name it, and sets aside terms the registry often files by mistake. A study open to many cancers is not placed under one of them unless its title names it.

Checked against studies judged one by one; the study page says when it differs from the registry.